Patent application number | Description | Published |
20090123510 | Medical implants containing adenosine receptor agonists and methods for inhibiting medical implant loosening - The invention provides methods and compositions for reducing or inhibiting bone resorption, osteoclast differentiation and stimulation and the loosening of medical prostheses by administering a compound or agent that modulates an adenosine receptor such as the adenosine A | 05-14-2009 |
20090208550 | Methods and compositions for treating hepatic diseases - The invention provides methods and compositions for treating a hepatic disease, for reducing fat deposition in the liver and for inhibiting fibrosis of the liver by administering a compound or agent that modulates an adenosine receptor, in particular, an inhibitor or antagonist of an adenosine receptor, especially an A | 08-20-2009 |
20120283211 | MEDICAL IMPLANTS CONTAINING ADENOSINE RECEPTOR AGONISTS AND METHODS FOR INHIBITIING MEDICAL IMPLANT LOOSENING - The invention provides methods and compositions for reducing or inhibiting bone resorption, osteoclast differentiation and stimulation and the loosening of medical prostheses by administering a compound or agent that modulates an adenosine receptor such as the adenosine A | 11-08-2012 |
20140112939 | Methods for Inhibiting Osteolysis - The invention provides methods and compositions for reducing or inhibiting osteolysis, bone resorption, osteoclast differentiation and stimulation and the loosening of medical prostheses by administering a compound or agent that inhibits the biological activity of an axon guidance protein. The compound or agent my inhibit transcription or translation of or bind to an axon guidance protein, such as, for instance, a netrin like netrin-1. Likewise, the compound or agent may inhibit transcription or translation of or bind to a receptor of an axon guidance protein, such as, for instance, a netrin receptor such as unc5b. In some instances, the compound or agent is an agonist of an adenosine A | 04-24-2014 |